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Abstract The aim of the present study was to investigate
the prevalence of obstructive sleep apnea syndrome
(OSAS) among the Norwegian population with Treacher
Collins syndrome (TCS). A secondary aim was to establish
whether TCS phenotype severity is associated with OSAS
severity. A prospective case study design was used. Indi-
viduals who were 5 years old and above with a known
diagnosis of TCS in Norway were invited to participate in a
study. The study included genetic testing, medical and
dental examinations and polysomnography. All partici-
pants demonstrated disturbed respiration during sleep;
18/19 met the diagnostic criteria for OSAS. Subjectively
evaluated snoring was not a reliable predictor of OSAS.
We found no signiﬁcant association between TCS pheno-
type severity and the severity of OSAS. OSAS is common
in TCS, but there is no association with the phenotype
severity. Individuals diagnosed with TCS must undergo
sleep studies to identify the presence of OSAS.
Keywords Sleep apnea  Craniofacial syndromes 
Phenotype  Snoring
Introduction
Obstructive sleep apnea syndrome (OSAS) is a common
disorder, affecting 2–4% of children and adults [1–3].
Narrowing of the upper airways is a primary risk factor for
OSAS [4]. This syndrome is caused by partial or complete
obstruction of the upper airways during sleep despite
ongoing inspiratory effort. These respiratory events lead to
episodes of oxygen desaturation and sleep disruption,
which harm the individual’s physical and mental health [5–
7]. OSAS is common among patients with craniofacial
deformities [8]. The development of upper airway skeletal
and soft tissue components is inﬂuenced by genetic factors,
and an intricate relationship between these components
determines the ultimate shape, patency and function of
the upper airways. The obstructions in craniofacial syn-
dromes are located at multiple sites in the upper airways,
often caused by hypoplasia of the maxilla and/or the
mandible.
Treacher Collins Syndrome (TCS) is an autosomal
dominant disorder of craniofacial development with an
incidence of approximately 1 in 50,000 live births [9,
10]. Penetrance of the genetic mutations underlying
TCS is high, yet inter- and intra-familial variation in
the severity of the phenotype is a striking feature of the
condition [11, 12]; 60% of cases are assumed to be de
novo mutations [13, 14]. Features characterising TCS
include bilateral downward slanting palpebral ﬁssures,
frequently accompanied by colobomas of the lower
eyelid with a paucity of eyelashes medial to the defect;
abnormalities of the external ear, atresia of the auditory
canal, and bilateral conductive hearing loss; hypoplasia
of the zygomatic complex and mandible; and cleft
palate [12, 15]. Although people with TCS are con-
sidered at high risk for developing OSAS [16]d u et o
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[16, 17].
The aim of the present study was to examine all indi-
viduals from 5 years of age with a known diagnosis of
Treacher Collins syndrome (TCS) in Norway for OSAS. A
secondary aim was to establish whether TCS phenotype
severity is associated with OSAS severity. OSAS poses a
health risk for these individuals, with potential effects on
cognitive function, work and school performance, and,
possibly, mortality.
Methods
Patients
An invitation to an extended medical examination was sent
to all patients aged 5 and above in October 2008 registered
at the TAKO centre (a national resource centre for oral
health in rare medical conditions), Lovisenberg Diakonale
Hospital, Department of Medical Genetics and Centre for
Rare Disorders, Oslo University Hospital, Rikshospitalet
and seven centres in the Norwegian Resource System for
persons with deaf blindness. Requests were also addressed
to the Departments of Medical Genetics at all university
hospitals in Norway and the support group Norwegian
Craniofacial Association.
This resulted in 36 eligible subjects with TCS who were
invitedtoattendand23acceptedtoparticipate.TheRegional
Committee for Medical Research Ethics evaluated and rec-
ommendedthe studyprotocol.Allthe 23participantsgavean
informed consent. Below 16 years of age, informed consent
was obtained by the child and their parents.
Medical and oral examination
A clinical geneticist saw all patients for diagnostic pur-
poses. Patients from families with unknown mutation status
were offered genetic testing as part of the routine clinical
work-up. Genetic testing (Sanger sequencing) was per-
formed by a clinical genetic laboratory. Eligible partici-
pants not thought to fulﬁl a clinical diagnosis of TCS and in
whom genetic testing was not performed (or negative) were
excluded from the study.
In addition, participants underwent a full ear nose and
throat examination including endoscopic evaluation of the
upper airway from the same experienced otorhinolaryn-
gologist. They underwent a hearing test by a certiﬁed
audiologist. They were all asked speciﬁc questions about
symptoms of possible sleep apnoea syndrome. They spent
the night in hospital for a polysomnography (PSG) evalu-
ation. Body mass index was calculated from weight and
height (kg/m
2).
This collaborative study also included examinations of
intraoral conditions and salivary secretion by a specialist in
paediatric dentistry. Dental casts were made and lateral
cephalogram and orthopantomogram taken. All underwent
ultrasound examinations of the major salivary glands. A
speech and language pathologist assessed orofacial func-
tions. Participants from school age answered a package of
quality of life-questionnaires.
Phenotypic expression
The patients were classiﬁed according to a system devel-
oped by Teber et al. in 2004 [18], as a method for quan-
tifying phenotypic expression in TCS patients. The main
clinical features (downward slanting palpebral ﬁssures,
lower eyelid coloboma, hypoplasia of zygomatic complex,
hypoplasia of mandible, microtia) scored two points each.
Accessory features (cleft palate, atresia of external ear
canal, conductive deafness, tracheostoma, choanal stenosis/
atresia, preauricular tags, delayed motor development,
delayed speech development) scored one point each. The
geneticist and otorhinolaryngologist registered all features,
except delayed motor and speech development, at clinical
examinations. Information of development was collected
by anamnestic interviews. Conductive deafness was
deﬁned as hearing loss over 25 dB. The overall facial
phenotype was classiﬁed as mild (scored with one point) or
severe (scored with two points) based on photographs
viewed by all collaborators.
The maximum sum of scores is 20 points if all relevant
data are available. Patients with a score of 0–10/20 are
regarded as mildly affected and patients with scores 11–20/
20 are regarded as severely affected. If available data are
incomplete, the maximum score will be less than 20.
Hearing tests
Hearing loss was measured using pure-tone audiometry,
according to recommended procedures (ISO 8253-1 1989).
A Madsen Auricle audiometer calibrated according to ISO
standards (ISO 389-1 1998, ISO 389-3 1994) was used.
The test was carried out in a quiet room. Air conduction
thresholds were obtained separately for the left and right
ear. The frequencies 500, 1,000, 2,000, 4,000 Hz, WHO
(World Health Organization) M4, were used to estimate
mean hearing loss.
Polysomnography
All patients underwent attended overnight Polysomnogra-
phy (PSG) (Embla, Resmed, Norway) at the Sleep Labo-
ratory, Lovisenberg Diakonale Hospital, Oslo, Norway. In
the children, there were also performed simultaneously
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123video and audio recordings. The PSG recordings included a
four-channel electroencephalogram (EEG) (C3/A2, C4/A1,
O2/A1, O4/A2), right and left electrooculogram (EOG),
and submental electromyogram (EMG). Ribcage and
abdominal wall movements were measured using respira-
tory inductance plethysmography. Flow was measured with
nasal pressure transducer and the arterial oxygen saturation
was monitored via pulse oximetry. Electrocardiogram
(ECG), body position and EMG from both legs were also
included.
Sleep was scored for sleep stages according to the
guidelines from Rechtschaffen and Kales [19]. Arousals
were deﬁned according to American Sleep Disorders
Association criteria [20]. In the adults, apnea was deﬁned
as a more than 90% reduction of ﬂow for more than 10 s.
They were classiﬁed as obstructive in the presence of rib-
cage and abdominal wall movements and central with
absent respiratory effort. Hypopneas were deﬁned as a
more than 50% decrease in ﬂow for more than 10 s with
subsequent oxygen desaturation of at least 3% or an
arousal. In the children, an obstructive apnea was deﬁned
as at least two breaths with more than 90% reduction in
ﬂow in the presence of ribcage and abdominal movement.
A central apnea was deﬁned as at least two breaths with
more than 90% reduction without absent respiratory effort
with subsequent oxygen desaturation of at least 3% or an
arousal, or if the event lasts for more than 20 s. Hypopneas
were deﬁned as a more than 50% decrease in ﬂow for at
least two breaths with subsequent oxygen desaturation of at
least 3% or an arousal [21]. The hypopneas were not
classiﬁed further for either the adults or the children.
Apnea hypopnea index (AHI) was deﬁned as the number
of apneas and hypopneas per hour of sleep, while oxygen
desaturation index (ODI) was deﬁned as the number of
oxygen desaturations C3% per hour of sleep. Mild
obstructive sleep apnea (OSA) was deﬁned as AHI 5–15 in
adults and AHI 1–5 in children, moderate OSA as AHI
15–30 in adults and AHI 5–10 in children and severe OSA
as AHI[30 in adults AHI[10 in children.
For estimating snoring, we used a VAS-scale, where the
participants were asked to assess how often they snore. The
parents ﬁlled in the score for children younger than
18 years of age.
Statistical analysis
The analysis was performed using SPSS 18.0 for Windows
(SPSS INC., Chicago, IL, USA). Descriptive analysis was
used to examine and present the data. The Pearson v
2 was
used to test if there were differences in the clinical phe-
notype features between the severity groups of OSA. The
level of signiﬁcance was established at 5%.
Results
As a result of clinical and genetic examinations, two par-
ticipants were excluded from the analyses due to uncon-
ﬁrmed TCS diagnosis. A further two individuals were
excluded due to the presence of an additional neuromus-
cular condition, which could inﬂuence orofacial function
and breathing. The study group thus consisted of 19 indi-
viduals between the ages 5 and 74 from 14 families. Par-
ticipants between 5 and 18 years of age were classed as
children in the analysis. Table 1 deﬁnes the basic charac-
teristics of the sample. Based on BMI, the majority of
participants were of normal weight or below.
Results of genetic testing were available for 17/19 par-
ticipants (13/14 families). The causative mutation was
detected in all but three families (mutation detection rate
10/13 = 77%). No mutations were found in more than one
family. Mutations were predicted to lead to loss of function
of the gene in all families. The sample was too small to
permit genotype-phenotype analyses.
Table 2 describes the participants’ phenotypic charac-
teristics. Among our group the most common features were
downward slanting palpebral ﬁssures (15/19), hypoplasia
of the zygomatic complex (16/19), hypoplasia of the
mandible (17/19), conductive hearing loss (17/19) and
atresia of the external ear canal (11/19). Cleft palate was
present in ﬁve cases. Two of the adults have developed
unilateral facial palsy in association with corrective sur-
gery. Based on the sum of scores from clinical ﬁndings, 13
individuals were classiﬁed as severely affected and 6 as
mildly affected.
The PSG demonstrated that all participants experienced
breathing disturbances during sleep. The mean AHI (SD)
was 30 (21.5) for adults and 5 (4.3) for children. Table 3
describes the distribution of severity of OSA among chil-
dren and adults. All the adults, and all but one of the
children, met the diagnostic criteria for OSA. In this child,
we observed snoring and ﬂattening of the ﬂow curve,
indicating increased resistance in the upper airway. 72.8%
of the adults and 37.5% of the children presented with
moderate to severe OSA. In both adults and children, the
Table 1 Basic characteristics of the participants (N = 19)
Children (n = 8) Adults (n = 11)
Mean SD Mean SD
Age 11.0 4.7 47.2 13.2
BMI 17.7 4.6 25.9 5.0
Gender Female Male Female Male
62 74
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123majority of the respiratory events were obstructive. AHI
varied greatly between participants. Deeper oxygen desat-
urations were observed in the adults than in the children.
All the adults scored 4.8 or more on the VAS-scale for
subjective snoring. The children had variable distribution
of registrations along the VAS-scale (0.0–9.0). We found
no correlation between AHI and subjectively evaluated
snoring. Table 4 shows the respiratory events and oxygen
saturation statistics together with each participant’s score
for subjective snoring.
We did not ﬁnd a signiﬁcant difference in AHI
according to the severity of phenotype by clinical ﬁndings,
but there was a tendency for higher AHI among partici-
pants with the severe phenotype (Fig. 1). The contributions
of each of the single features were tested, and neither of
these was signiﬁcantly related to OSA.
Discussion
The increased incidence of OSAS in patients with cranio-
facial deformities is well-known [22, 23], but there are only
a few case reports considering OSAS in TCS. All but one
of our study participants had OSAS. Diagnosis and treat-
ment is important as OSAS poses serious health risks,
including cardiovascular disease and impaired cognitive
development [24–26].
During the last 50 years, there have been approximately
50,000–60,000 births per year in Norway. Assuming an
annual incidence rate of 1:50,000 and some perinatal
mortality, there may have been 60–80 TCS cases in Nor-
way during this period. We acknowledge that some indi-
viduals with mild phenotype may be unidentiﬁed, but
believe that all the individuals currently diagnosed with
TCS in Norway were invited to participate in the study.
Our case series has a severity score comparable with that
of Teber et al.: 13/19 (68%) severe cases in this case series
compared with 26/35 (74%) in Teber et al. We do not know
if there are differences between the sample investigated
and the individuals who chose not to participate. Interest-
ingly, some of those who did not participate were later
diagnosed with obstructive sleep apnea. In conclusion, we
believe the sample investigated is representative of the
Norwegian TCS population and typical of a population
presenting to the health service with this diagnosis.
Based on clinical ﬁndings applied to the system devel-
oped by Teber et al. 13 (68%) participants were classiﬁed
Table 4 Respiratory disturbances recorded by PSG, the ﬁrst 11 are
adults, the last 8 are children
ID AHI ODI Lowest
SAO2
Average
SaO2
Subjective
snoring
1 21.7 17.0 88 94.5 5.1
2 7.8 8.5 89 94.9 7.8
3 38.6 21.7 89 95.8 4.8
4 32.5 20.0 83 95.0 6.9
5 75.0 61.6 82 95.7 10.0
6 63.7 57.2 81 94.7 10.0
7 21.6 19.9 89 94.7 10.0
8 25.1 22.8 87 95.5 10.0
9 18.1 10.3 85 93.7 5.6
10 12.1 24.1 80 92.6 9.4
11 14.0 13.2 81 96.2 10.0
12 5.1 5.5 89 96.6 7.3
13 1.5 0.9 94 97.2 5.5
14 8.4 6.9 92 97.7 9.0
15 7.7 3.0 93 98.0 3.0
16 12.7 15.8 80 96.4 0.0
17 1.7 1.5 94 97.5 7.8
18 1.8 6.2 91 96.8 8.0
19 0.7 0.2 91 98.2 3.0
Fig. 1 Distribution of AHI grouped by severity of OSA and
separated according to severity of clinical ﬁndings
Table 3 Distribution of AHI grouped by severity of OSA in children
and adults
Children (n = 8) Adults (n = 11)
n % n %
None 1 12.5 0 0.0
Mild OSAS 4 50.0 3 27.3
Moderate OSAS 2 25.0 4 36.4
Severe OSAS 1 12.5 4 36.4
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123with a severe phenotype of TCS. There was no signiﬁcant
difference in AHI between the severe and mild phenotype,
but this could be due to the small number of subjects in our
study group. The use of standard clinical scoring systems
across studies might permit meta-analyses to clarify this
question in the future.
Not all of the speciﬁc features of TCS are likely to cause
OSA. Hypoplasia of the mandible and zygomatic complex,
cleft palate and choanal atresia are known contributors to
narrowing of the airway. We therefore tested each of these
speciﬁc features against severity groups of OSA. We did
not ﬁnd any signiﬁcant correlation, but again the low
number of participants probably causes this. Delayed
speech development is seen in many of the patients. This
may be caused by hearing loss, but also OSA can con-
tribute to delay of speech because of cognitive impairment
due to sleep disruption and oxygen desaturation [27].
The only participant who did not have OSAS, was
classiﬁed clinically as having the severe phenotype (19,
score 12/20). This demonstrates that clinical examination
and severity of the phenotype are not sufﬁcient to exclude
OSAS. Subjectively evaluated snoring in people with TCS
was also not a reliable clinical indicator of OSAS. A PSG
must be carried out in order to conﬁrm the presence or
absence of OSAS. In children with TCS, it is advisable that
the PSG is repeated throughout childhood since the size of
the airways and the soft tissue (adenoids and tonsils) alters
as the child develops. Some children with OSAS may
beneﬁt from treatment with continuous positive airway
pressure (CPAP) until suitable conditions for corrective
surgery are obtained [28]. Case reports have indicated that
corrective surgery of the mandible is an effective treatment
for OSAS [16]. Although most of the adults in our group
had undergone corrective surgery to improve respiration,
they continued to experience moderate to severe OSAS.
This ﬁnding demonstrates the importance of post-surgical
retesting in order to identify persisting sleep apnea.
Conclusion
All patients in this study presented with breathing distur-
bances during sleep. Only one had been diagnosed prior to
the study. This indicates a high prevalence of obstructive
sleep apnea syndrome in TCS and highlights the value of
offering diagnostic sleep studies to all individuals diag-
nosed with TCS. The severity of TCS phenotype could not
be used to estimate the degree of OSA. The timing and
frequency of sleep studies should be evaluated on an
individual basis.
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